Free Trial

TD Cowen Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $66.00

Acadia Healthcare logo with Medical background

Acadia Healthcare (NASDAQ:ACHC - Free Report) had its target price trimmed by TD Cowen from $70.00 to $66.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and upped their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Barclays lowered their price target on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. Cantor Fitzgerald reiterated a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a research report on Monday, November 18th. Finally, StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Acadia Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.

View Our Latest Analysis on ACHC

Acadia Healthcare Price Performance

ACHC traded up $0.28 during trading on Tuesday, hitting $45.13. 2,328,060 shares of the stock traded hands, compared to its average volume of 2,337,040. The business has a 50 day moving average price of $40.57 and a 200 day moving average price of $58.37. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market cap of $4.19 billion, a price-to-earnings ratio of 14.80, a PEG ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 earnings per share. Equities research analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of ACHC. Commonwealth Equity Services LLC increased its holdings in shares of Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company's stock valued at $513,000 after purchasing an additional 257 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Acadia Healthcare by 2.9% in the second quarter. Victory Capital Management Inc. now owns 268,264 shares of the company's stock valued at $18,119,000 after acquiring an additional 7,467 shares during the period. Arizona State Retirement System grew its holdings in shares of Acadia Healthcare by 2.1% during the second quarter. Arizona State Retirement System now owns 25,874 shares of the company's stock worth $1,748,000 after buying an additional 531 shares during the last quarter. Texas Permanent School Fund Corp increased its holdings in shares of Acadia Healthcare by 11.3% in the second quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company's stock valued at $6,067,000 after purchasing an additional 9,115 shares during the period. Finally, American Century Companies Inc. increased its stake in Acadia Healthcare by 5.7% in the 2nd quarter. American Century Companies Inc. now owns 429,713 shares of the company's stock valued at $29,023,000 after buying an additional 23,033 shares during the period.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines